Cerevel Therapeutics Hldng I shares owned by Credit Suisse
Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Credit Suisse
from 13F filings
Historical chart of Credit Suisse investment in Cerevel Therapeutics Hldng I
Tip: Access up to 7 years of quarterly data
All positions including Cerevel Therapeutics Hldng I held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cerevel Therapeutics Hldng I by Credit Suisse
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $7.4M | 175k | 42.40 |
| 2023-09-30 | $1.3M | 62k | 21.83 |
| 2023-06-30 | $2.3M | 73k | 31.79 |
| 2023-03-31 | $1.4M | 56k | 24.39 |
| 2022-12-31 | $1.7M | 56k | 31.54 |
| 2022-09-30 | $1.4M | 50k | 28.29 |
| 2022-06-30 | $1.3M | 49k | 26.48 |
| 2022-03-31 | $1.3M | 37k | 34.95 |
| 2021-12-31 | $1.0M | 32k | 32.45 |
| 2021-09-30 | $811k | 28k | 29.49 |
| 2021-06-30 | $386k | 15k | 25.32 |
| 2021-03-31 | $178k | 13k | 13.76 |